porphozym
Recombinant proteinexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2003 (NCT00418795)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Porphobilinogen deaminaseSupplementation
HMBS supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS5AE6296X3G ↗
Also known as
- porphozym
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00418795 | Phase 2 | Feb 1, 2003 | Umea University, Zymenex |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Umea University | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Zymenex | For profit | 1 | 1 | 1 | 2003 |
2 organizations
Page 1 / 1